Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank I Tarazi

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|August 3, 2021
Dopamine D3 Receptors: From Bench to BedsideXenia Gonda, Frank I. Tarazi
Drugs of Today (Barcelona, Spain : 1998)|February 6, 2010
Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar maniaFrank I Tarazi, Mohammed Shahid
BMB Reports|September 18, 2010
Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr-/- mice: relevance to schizophreniaYong Kee Choi, Frank I Tarazi
The International Journal of Neuropsychopharmacology|April 3, 2001
Brain dopamine D(4) receptors: basic and clinical statusFrank I. Tarazi, Ross J. Baldessarini
Journal of Molecular Neuroscience : MN|August 10, 2018
Long-Term Effects of Iloperidone on Cerebral Serotonin and Adrenoceptor SubtypesYong Kee Choi, Frank I Tarazi
Expert Opinion on Drug Discovery|October 20, 2017
Pimavanserin: novel pharmacotherapy for Parkinson's disease psychosisZeyad T Sahli, Frank I Tarazi
Synapse (New York, N.Y.)|June 24, 2018
Long-term effects of iloperidone on cerebral dopamine receptor subtypesYong Kee Choi, Frank I Tarazi
Expert Opinion on Drug Discovery|July 11, 2013
The preclinical profile of lurasidone: clinical relevance for the treatment of schizophreniaFrank I Tarazi, Marco A Riva
Expert Opinion on Pharmacotherapy|August 2, 2012
Iloperidone, asenapine and lurasidone: a primer on their current statusFrank I Tarazi, Stephen M Stahl
Expert Opinion on Drug Discovery|November 6, 2012
The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar maniaFrank I Tarazi, Jo C Neill
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|August 3, 2021
Dopamine D3 Receptors: From Bench to BedsideXenia Gonda, Frank I. Tarazi
Drugs of Today (Barcelona, Spain : 1998)|February 6, 2010
Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar maniaFrank I Tarazi, Mohammed Shahid
BMB Reports|September 18, 2010
Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr-/- mice: relevance to schizophreniaYong Kee Choi, Frank I Tarazi
The International Journal of Neuropsychopharmacology|April 3, 2001
Brain dopamine D(4) receptors: basic and clinical statusFrank I. Tarazi, Ross J. Baldessarini
Journal of Molecular Neuroscience : MN|August 10, 2018
Long-Term Effects of Iloperidone on Cerebral Serotonin and Adrenoceptor SubtypesYong Kee Choi, Frank I Tarazi
Expert Opinion on Drug Discovery|October 20, 2017
Pimavanserin: novel pharmacotherapy for Parkinson's disease psychosisZeyad T Sahli, Frank I Tarazi
Synapse (New York, N.Y.)|June 24, 2018
Long-term effects of iloperidone on cerebral dopamine receptor subtypesYong Kee Choi, Frank I Tarazi
Expert Opinion on Drug Discovery|July 11, 2013
The preclinical profile of lurasidone: clinical relevance for the treatment of schizophreniaFrank I Tarazi, Marco A Riva
Expert Opinion on Pharmacotherapy|August 2, 2012
Iloperidone, asenapine and lurasidone: a primer on their current statusFrank I Tarazi, Stephen M Stahl
Expert Opinion on Drug Discovery|November 6, 2012
The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar maniaFrank I Tarazi, Jo C Neill
Pageof 8